Found 7 matching trials
Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of combina...
Show More Location
Asan Medical Center
Learn More & Join Trial
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC PHASE3 The primary purpose of this study is to determine the non-inferiority of ov...
Show More Location
NPO Epidemiological and Clinical Research Information Network (ECRIN)
Learn More & Join Trial
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma PHASE2 This phase Ⅱ study was designed to evaluate the efficacy and safety of FOLF...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer N/A The goal of this clinical trial is to test in biliary tract cancer patients...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). PHASE2 To evaluate the efficacy and safety of SOX or mFOLFOX6 as neoadjuvant chemo...
Show More Location
Kyushu University Hospital
Learn More & Join Trial
Characterization of priMary And sEcondary STress Related takOtsubo NA Takotsubo syndrome (TTS) is an acute and reversible form of myocardial inju...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC PHASE3 The primary purpose of this study is to determine the non-inferiority of ov...
Show More Location
Cancer center of Sun Yat-sen University
Learn More & Join Trial